PYXS
Price:
$1.56
Market Cap:
$97.13M
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for tre...[Read more]
Industry
Biotechnology
IPO Date
2021-10-08
Stock Exchange
NASDAQ
Ticker
PYXS
According to Pyxis Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 105.81M. This represents a change of 9.44% compared to the average of 96.69M of the last 4 quarters.
The mean historical Enterprise Value of Pyxis Oncology, Inc. over the last ten years is 169.50M. The current 105.81M Enterprise Value has changed 6.14% with respect to the historical average. Over the past ten years (40 quarters), PYXS's Enterprise Value was at its highest in in the March 2021 quarter at 300.15M. The Enterprise Value was at its lowest in in the June 2022 quarter at -130439168.20.
Average
169.50M
Median
87.70M
Minimum
-116107671.46
Maximum
445.58M
Discovering the peaks and valleys of Pyxis Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.07%
Maximum Annual Enterprise Value = 445.58M
Minimum Annual Increase = -247.13%
Minimum Annual Enterprise Value = -116107671.46
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 91.90M | 10.07% |
| 2023 | 83.50M | -171.91% |
| 2022 | -116107671.46 | -247.13% |
| 2021 | 78.92M | -82.29% |
| 2020 | 445.58M | 2.86% |
The current Enterprise Value of Pyxis Oncology, Inc. (PYXS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.76M
5-year avg
116.76M
10-year avg
169.50M
Pyxis Oncology, Inc.’s Enterprise Value is less than Enanta Pharmaceuticals, Inc. (443.96M), greater than Immuneering Corporation (-46854362.00), less than Foghorn Therapeutics Inc. (271.21M), less than Caribou Biosciences, Inc. (152.65M), less than Voyager Therapeutics, Inc. (214.53M), greater than Tenaya Therapeutics, Inc. (86.83M), less than Atea Pharmaceuticals, Inc. (229.18M), less than Zura Bio Limited (253.07M), less than Humacyte, Inc. (157.44M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 443.96M | $275.21M | |
| -46854362.00 | $176.79M | |
| 271.21M | $338.02M | |
| 152.65M | $138.33M | |
| 214.53M | $221.29M | |
| 86.83M | $131.62M | |
| 229.18M | $305.48M | |
| 253.07M | $392.09M | |
| 157.44M | $147.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pyxis Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pyxis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pyxis Oncology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Pyxis Oncology, Inc. (PYXS)?
What is the 3-year average Enterprise Value for Pyxis Oncology, Inc. (PYXS)?
What is the 5-year average Enterprise Value for Pyxis Oncology, Inc. (PYXS)?
How does the current Enterprise Value for Pyxis Oncology, Inc. (PYXS) compare to its historical average?